BBA
JBIO
Baker Bros. Advisors’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-628,939
| Closed | -$1.31M | – | 97 |
|
2024
Q3 | $1.31M | Hold |
628,939
| – | – | 0.01% | 84 |
|
2024
Q2 | $1.04M | Sell |
628,939
-1,051,578
| -63% | -$1.75M | 0.01% | 86 |
|
2024
Q1 | $49.7M | Hold |
1,680,517
| – | – | 0.62% | 25 |
|
2023
Q4 | $38M | Sell |
1,680,517
-282,962
| -14% | -$6.4M | 0.43% | 28 |
|
2023
Q3 | $26.6M | Hold |
1,963,479
| – | – | 0.15% | 31 |
|
2023
Q2 | $33.7M | Hold |
1,963,479
| – | – | 0.19% | 32 |
|
2023
Q1 | $39.6M | Sell |
1,963,479
-13,389
| -0.7% | -$270K | 0.22% | 25 |
|
2022
Q4 | $57.9M | Sell |
1,976,868
-2,700
| -0.1% | -$79.1K | 0.35% | 23 |
|
2022
Q3 | $32.8M | Sell |
1,979,568
-90,442
| -4% | -$1.5M | 0.21% | 34 |
|
2022
Q2 | $32.4M | Hold |
2,070,010
| – | – | 0.18% | 34 |
|
2022
Q1 | $37.9M | Buy |
2,070,010
+238,221
| +13% | +$4.37M | 0.22% | 38 |
|
2021
Q4 | $21.6M | Buy |
1,831,789
+179,618
| +11% | +$2.12M | 0.11% | 57 |
|
2021
Q3 | $34.7M | Buy |
1,652,171
+223,600
| +16% | +$4.69M | 0.15% | 48 |
|
2021
Q2 | $32.6M | Buy |
+1,428,571
| New | +$32.6M | 0.14% | 52 |
|